Human health benefits and burdens of a pharmaceutical treatment: Discussion of a conceptual integrated approach
- 1 January 2016
- journal article
- review article
- Published by Elsevier in Environmental Research
- Vol. 144, 19-31
Abstract
No abstract availableKeywords
Funding Information
- Flemish agency for Innovation by Science and Technology (140249)
This publication has 84 references indexed in Scilit:
- Reduced resource consumption through three generations of Galantamine·HBr synthesisGreen Chemistry, 2013
- Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitationHealth and Quality of Life Outcomes, 2008
- The NICE Cost-Effectiveness ThresholdPharmacoEconomics, 2008
- On future non‐medical costs in economic evaluationsHealth Economics, 2007
- The ecoinvent database system: a comprehensive web-based LCA databaseJournal of Cleaner Production, 2005
- Cost-Effectiveness of Lopinavir/Ritonavir Versus Nelfinavir As the First-Line Highly Active Antiretroviral Therapy Regimen for HIV InfectionHIV Research & Clinical Practice, 2004
- Discounting in Cost-Utility Analysis of Healthcare InterventionsPharmacoEconomics, 2003
- Willingness to Pay for a Quality-adjusted Life YearMedical Decision Making, 2000
- Economic foundations of cost-effectiveness analysisJournal of Health Economics, 1997
- An economic approach to clinical trial design and research priority-settingHealth Economics, 1996